These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
5. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296 [TBL] [Abstract][Full Text] [Related]
6. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma? Quera R; O'Sullivan K; Quigley EM Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of Barrett's high-grade dysplasia. Weston AP; Sharma P; Topalovski M; Richards R; Cherian R; Dixon A Am J Gastroenterol; 2000 Aug; 95(8):1888-93. PubMed ID: 10950031 [TBL] [Abstract][Full Text] [Related]
9. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135 [TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus: a retrospective analysis of 13 years surveillance. Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769 [TBL] [Abstract][Full Text] [Related]
11. Barrett's surveillance identifies patients with early esophageal adenocarcinoma. Wong T; Tian J; Nagar AB Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324 [TBL] [Abstract][Full Text] [Related]
12. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666 [TBL] [Abstract][Full Text] [Related]
13. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761 [TBL] [Abstract][Full Text] [Related]
14. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma]. Incarbone R; Bonavina L; Bassi F; Peracchia A Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454 [TBL] [Abstract][Full Text] [Related]
15. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768 [TBL] [Abstract][Full Text] [Related]
16. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Provenzale D; Schmitt C; Wong JB Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526 [TBL] [Abstract][Full Text] [Related]
17. A surveillance programme for Barrett's oesophagus in a UK general hospital. Olithselvan A; Gorard DA; McIntyre AS Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694 [TBL] [Abstract][Full Text] [Related]
18. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy. Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102 [TBL] [Abstract][Full Text] [Related]
19. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
20. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD]. Endzinas Z; Mickevicius A; Kiudelis M Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]